Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Gilead Vs. AbbVie: A DGI Thunderdome Match
Seeking Alpha
Mon, 05/8/17 - 09:55 pm
Gilead Sciences
AbbVie
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
AbbVie
Imbruvica
non-Hodgkin's lymphoma
mantle cell lymphoma
graft vs host disease
AbbVie Reports Humira Sales Growth in 1st Quarter
Yahoo/GuruFocus
Sun, 04/30/17 - 12:49 pm
AbbVie
Humira
earnings
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
earnings
drug pricing
Biogen
Eli Lilly
AbbVie
Allergan
Merck
Pfizer
Amgen
AbbVie stock surges 1.5% after first-quarter profit, revenue beats
Marketwatch
Thu, 04/27/17 - 09:42 am
AbbVie
earnings
Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
earnings
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Sanofi
Failure Of Abbvie's Cancer Drug Hasn't Hurt The Stock
Barron's
Fri, 04/21/17 - 11:28 am
AbbVie
veliparib
AbbVie, Enanta post stellar hep C PhIII data, but no one is cheering
Endpoints
Thu, 04/20/17 - 08:52 pm
AbbVie
Enanta
hepatitis C
glecaprevir/pibrentasvir
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Fierce Pharma
Wed, 04/19/17 - 04:21 pm
earnings
drug pricing
Bristol-Myers Squibb
AbbVie
Roche
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:09 pm
Eli Lilly
Inctye
AbbVie
Regeneron
rheumatoid arthritis
FDA
baricitinib
Humira
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Eli Lilly
Pfizer
Sanofi
AbbVie
Regeneron
patents
PCSK9 inhibitors
Repatha
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
Fierce Pharma
Sat, 04/1/17 - 08:14 am
JNJ
Pfizer
Merck
AbbVie
Eli Lilly
Bristol-Myers Squibb
How AbbVie Is Attacking Tumors at Their Roots
Motley Fool
Wed, 03/29/17 - 09:06 am
AbbVie
solid tumors
cancer
stem cells
Stemcentrx
Rova-T
3 Things You Probably Didn't Know About AbbVie Inc.
Motley Fool
Tue, 03/28/17 - 10:16 am
AbbVie
dividends
debt
AbbVie's Hepatitis C Treatment Under Priority Review in Japan
Yahoo/GuruFocus
Wed, 03/15/17 - 09:47 pm
AbbVie
hepatitis C
Japan
glecaprevir/pibrentasvir
AbbVie chief's $20M-plus pay—and company jet-setting—headed skyward in 2016
Fierce Pharma
Fri, 03/10/17 - 09:53 am
AbbVie
Pharma CEOs
executive pay
Richard Gonzalez
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
Endpoints
Wed, 02/22/17 - 11:43 am
M&A
Shire
Baxalta
Pfizer
Medivation
Mylan
Meda
AbbVie
Stemcentrx
Anacor
AbbVie Announces $5 Billion Increase to Stock Repurchase Program
Yahoo
Sat, 02/18/17 - 02:22 pm
AbbVie
stock buyback
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Pfizer
Xeljanz
AbbVie
Humira
rheumatoid arthritis
U.S. FDA Grants Priority Review to AbbVie for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Yahoo
Thu, 02/2/17 - 09:22 am
FDA
AbbVie
glecaprevir/pibrentasvir
G/P
hepatitis C
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »